Comments

Champions Oncology Stock Guidance

CSBRNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$5.77

-0.61-9.56%

At close: -

$7.15

1.3823.92%

After Hours: Apr 30, 4:02 PM EDT

Champions Oncology (CSBR) Forecast News Earnings Champions Oncology (CSBR) Options

Guidance

Dividends Analyst Ratings Insider Trades Short Interest

Champions Oncology Stock Guidance | NASDAQ:CSBR | Benzinga

Champions Oncology issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

											Get Alert
07/21/2022	CSBR	Champions Oncology	FY	2023	—	—	—	$58.93M	$58.93M	$57.19M	Get Alert
03/15/2022	CSBR	Champions Oncology	FY	2022	—	—	—	$47.20M	$49.25M	$48.29M	Get Alert
12/14/2020	CSBR	Champions Oncology	FY	2021	—	—	—	$38.55M	$40.15M	$38.56M	Get Alert

FAQ

Q

What is the most recent guidance for Champions Oncology (CSBR)?

A

There have been no specific sales or earnings guidance reported for Champions Oncology in recent months.

Browse guidance and forecast on all stocks.

People Also Watch